- L-Ornithine
- L-Ornithine (3-methyl-2-oxobutyrate)
- L-Ornithine (3-methyl-2-oxopentanoate)
- L-Ornithine 2-oxoglutarate
- L-Ornithine 2-oxoglutarate
- L-Ornithine acetate
- L-Ornithine L-aspartate salt
- L-Ornithine sulfate (2:1) monohydrate
- L-Ornithine, hydrochloride (1:2)
- L-Ornithine, N2-[(1,1-dimethylethoxy)carbonyl]-N5-[imino[[(2,4,6-trimethylphenyl)sulfonyl]amino]methyl]-
- 32314-39-9Quinoline,4-chloro-2,8-dimethyl-
- 32315-10-9Triphosgene
- 32316-92-02-Naphthaleneboronic acid
- 323196-43-64-Imidazolidinone,2,2,3-trimethyl-5-(phenylmethyl)-, hydrochloride (1:1), (5R)-
- 323197-73-54,6-Methano-1,3,2-benzodioxaborole-2-methanamine,hexahydro-3a,5,5-trimethyl-a-2-propen-1-yl-, (aR,3aS,4S,6S,7aR)-
- 32324-19-9Benzenesulfonylisocyanate, 2-methyl-
- 32326-14-0Benzenesulfonamide,4-amino-N-(5-methoxy-3-isoxazolyl)-
- 3232-62-0Bicyclo[2.2.1]hept-5-ene-2,3-dicarboxylicacid, 1,4,5,6,7,7-hexachloro-, 2,3-di-2-propen-1-yl ester
- 32326-25-33-Isoxazolamine,5-methoxy-
- 32327-48-35-ACETAMIDONAPHTHALENE-1-SULFONAMIDE
Hot Products
- 609-15-4Butanoicacid, 2-chloro-3-oxo-, ethyl ester
- 50-03-3Hydrocortisone acetate
- 643-79-8o-Phthalaldehyde
- 107133-36-8Perindopril erbumine
- 49805-30-32-Azabicyclo[2.2.1]hept-5-en-3-one
- 86-73-7Fluorene
- 89778-27-8Toremifene citrate
- 123-99-9Azelaic acid
- 104987-11-3Tacrolimus
- 141-53-7Sodium formate
- 8001-54-5Quaternary ammonium compounds, alkylbenzyldimethyl, chlorides
- 9003-39-8Povidone
- 10161-34-9Trenbolone acetate
- 402957-28-2Telaprevir
- 68-19-9Cyanocobalamin
|
Basic Information |
|
Post buying leads |
|
Suppliers |
|
Cas Database |
| Name |
L-Ornithine L-aspartate salt |
EINECS | 221-772-7 |
| CAS No. | 3230-94-2 | Density | N/A |
| PSA | 189.96000 | LogP | 0.11110 |
| Solubility | N/A | Melting Point |
202.0 to 206.0 °C |
| Formula | C5H12N2O2 | Boiling Point | 308.7 °C at 760 mmHg |
| Molecular Weight | 265.266 | Flash Point | 140.5 °C |
| Transport Information | N/A | Appearance | white powder |
| Safety | 26-37/39 | Risk Codes | 36/37/38 |
| Molecular Structure |
|
Hazard Symbols |
 Xi
|
| Synonyms |
Orparan;(2S)-2-amino-4-hydroxy-4-oxobutanoate; [(4S)-4-amino-;L-Ornithine, L-aspartate (1:1);Ornithine, L-, L-aspartate (1:1) (8CI);Aspartic acid compd. with ornithine;Hepamerz;Ormeta;Ornithine aspartate; |
Article Data | 5 |
L-Ornithine L-aspartate salt Synthetic route
| Conditions | Yield |
|---|---|
| With ammonium carbonate In methanol; water at 70 - 80℃; for 4.16667h; pH=7 - 8; Solvent; | 18.3 g |
| In methanol at 45℃; Solvent; | 21.3 g |
| Conditions | Yield |
|---|---|
| With zinc(II) chloride at 35 - 40℃; for 1.5h; pH=8.3; Reagent/catalyst; Temperature; pH-value; | 115 g |
L-Ornithine L-aspartate salt Specification
1. Introduction of L-Ornithine L-aspartate salt
L-Ornithine L-aspartate salt, with its IUPAC Name of (2S)-2-amino-4-hydroxy-4-oxobutanoate; [(4S)-4-amino-5-hydroxy-5-oxopentyl]azanium, is one kind of white crystalline powder. L-Ornithine L-Aspartate can be used for making amino acid injection in medical treatment of cirrhosis.
2. Properties of L-Ornithine L-aspartate salt
L-Ornithine L-aspartate salt has the following property datas: (1)H bond acceptors: 4; (2)H bond donors: 5; (3)Freely Rotating Bonds: 6; (4)Polar Surface Area: 29.54; (5)Flash Point: 140.5 °C; (6)Enthalpy of Vaporization: 60.42 kJ/mol; (7)Boiling Point: 308.7 °C at 760 mmHg; (8)Vapour Pressure: 0.00015 mmHg at 25°C.
3. Structure Descriptors of L-Ornithine L-aspartate salt
You could convert the following datas into the molecular structure:
(1)InChI: InChI=1S/C5H12N2O2.C4H7NO4/c6-3-1-2-4(7)5(8)9;5-2(4(8)9)1-3(6)7/h4H,1-3,6-7H2,(H,8,9);2H,1,5H2,(H,6,7)(H,8,9)/t4-;2-/m00/s1
(2)InChIKey: InChIKey=IXUZXIMQZIMPSQ-ZBRNBAAYSA-N
(3)Smiles: C([C@@H](C(=O)O)N)CC[NH3+].C([C@@H](C(=O)[O-])N)C(O)=O
4. Toxicity of L-Ornithine L-aspartate salt
| Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
|---|---|---|---|---|---|
| mouse | LD50 | intraperitoneal | > 5gm/kg (5000mg/kg) | Drugs in Japan Vol. 6, Pg. 164, 1982. | |
| mouse | LD50 | intravenous | 2gm/kg (2000mg/kg) | "Modern Pharmaceuticals of Japan, III," Tokyo, Japan Pharmaceutical, Medical and Dental Suppl Exporters' Assoc., 1968Vol. -, Pg. 91, 1968. | |
| mouse | LD50 | oral | 5gm/kg (5000mg/kg) | "Modern Pharmaceuticals of Japan, III," Tokyo, Japan Pharmaceutical, Medical and Dental Suppl Exporters' Assoc., 1968Vol. -, Pg. 91, 1968. | |
| mouse | LD50 | subcutaneous | > 5gm/kg (5000mg/kg) | Drugs in Japan Vol. 6, Pg. 164, 1982. |
5. Safety Information of L-Ornithine L-aspartate salt
Hazard Codes: Xi
Risk Statements: 36/37/38
36/37/38:Irritating to eyes, respiratory system and skin
Safety Statements: 26-37/39
26:In case of contact with eyes, rinse immediately with plenty of water and seek medical advice
37/39:Wear suitable gloves and eye/face protection
WGK Germany: 2
RTECS: CI9463000
What can I do for you?
Get Best Price
